SCHEMBL21190538

SCHEMBL21190538

c1ccc2c(c1)ccc1c3cccc(-c4ccc5ccc6c(-c7cccc8c7oc7c9ccccc9ccc87)ccc7ccc4c5c76)c3oc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.50
CDC25A P30304 1/20 0.50
CDC25C P30307 1/20 0.50
CYP1A2 P05177 8/20 0.44
HPGD P15428 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 3/20 0.44
THRB P10828 1/20 0.44
CYP1A1 P04798 6/20 0.41
CYP1B1 Q16678 6/20 0.41
PRKDC P78527 4/20 0.41
CYP3A4 P08684 2/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 2/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21190624 0.98 ARSA (0.49) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27127041 0.93 ARSA (0.45) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL12069175 0.91 CYP1A2 (0.44) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27126814 0.89 ARSA (0.46) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27126211 0.88 CYP1A2 (0.40) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27127212 0.88 CYP1A2 (0.40) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27126291 0.88 CYP1A2 (0.40) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27126227 0.87 CYP1A2 (0.42) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27127221 0.87 CYP1A2 (0.42) ARSACDC25ACDC25CCYP1A2HPGD
SCHEMBL27126987 0.87 ALOX5 (0.45) ARSACDC25ACDC25CCYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11139438-B2 Organic electroluminescent element KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2021-10-05 US disclosed
US-20190280209-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-09-12 US disclosed
US-20190229277-A1 ORGANIC ELECTROLUMINESCENT ELEMENT KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190229277-A1 ORGANIC ELECTROLUMINESCENT ELEMENT ELP1, NFE2L2, ESR2 ARSA 729/4885CDC25A 3494/4885CDC25C 3618/4885
US-11139438-B2 Organic electroluminescent element ELP1, NFE2L2, ESR2 ARSA 729/4885CDC25A 3494/4885CDC25C 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.